Brian Greene Tells LMU Graduates: Embrace Your Moment in the Cosmos with Curiosity and Gratitude
LOS ANGELES, May 18, 2025 /PRNewswire/ — Brian Greene, a leading theoretical physicist and sought-after communicator of groundbreaking scientific concepts, urged those gathered Sunday for Loyola Marymount University's graduate and LMU Loyola Law School commencement to appreciate their unique existence in the cosmos, embrace their potential, and approach life with gratitude.
Addressing a rapt crowd on LMU's sun-filled Westchester campus, the best-selling author told graduates 'we have each won the most improbable cosmic lottery.' See the press kit with images and Greene's commencement video HERE.
'Think about how utterly unlikely it is that you exist,' Greene said. 'Think about the nearly infinite collection of quantum processes stretching from The Big Bang until today … yet against those astounding odds – for a brief moment of time you exist, as do I.'
Drawing on discoveries from Albert Einstein to Stephen Hawking and Carl Sagan to Edwin Hubble, Greene traced for students and attendees the arc of scientific discovery allowing us to better understand our place in the universe, and the phenomenon of our capacity to live, comprehend, and connect with one another. Greene also noted the contributions of Jesuit-educated Catholic priest Georges Lemaître, who 'used Einstein's math to catch a glimpse of the possibility that space might be expanding,' an idea widely rejected at the time, only to be established a few years later.
'We can think about the past. We can imagine the future. We can take in the universe, mind and body, with reasoning and emotion allowing us to figure out astonishing things, like how stars shine and light travels, how black holes form and time elapses, allowing for creative achievements … all created by minds like yours, like mine, and that …most certainly will continue to create great beauty, to illuminate great mystery, to experience great wonder.'
This phenomenon of human existence, Greene concluded, 'should give us all a deep sense of connection. A kind of cosmic communion, and a sense that I can summarize with one word: gratitude.'
'Gratitude for being a small transient part of this wondrous unfolding, gratitude for our capacity to come together in groups that, at their best, allow us to each realize our potential, gratitude for our capacity for courage like that of George Lemaître, to stand up to authority, to not accept easy answers, and when necessary to fight for what we believe in. Gratitude that is for human existence, for fragile, delicate, difficult, challenging, painful, exhausting, beautiful, exquisite, transcendent, human existence, however brief, however evanescent, however fleeting.'
Greene is a lifelong learner committed to intellectual inquiry, educational access, and academic excellence. Described by The Washington Post as 'the single best explainer of abstruse concepts in the world today,' he is the author of four acclaimed books that have collectively sold millions of copies worldwide. His latest best-selling release, 'Until the End of Time,' which explores the cosmos and our quest to understand it, was named one of the '100 Notable Books of 2020' by The New York Times.
Greene's books have been adapted into two Emmy and Peabody Award-winning NOVA miniseries, both of which he hosted. With journalist Tracy Day, he co-founded the World Science Festival, whose flagship events in New York and Australia have reached an audience of more than two million people, and more than 250 million people online. Greene has appeared on 'The Late Show with Stephen Colbert,' played himself in an episode of 'The Big Bang Theory,' and made cameo appearances in films including 'Frequency,' 'Maze,' and 'The Last Mimzy.' A Harvard graduate and a Rhodes Scholar, he serves as director of Columbia University's Center for Theoretical Physics.
Nearly 2,900 LMU undergraduate, graduate, and law students participated in weekend commencement celebrations, which began Saturday with Ahmir 'Questlove' Thompson addressing the undergraduate commencement ceremony.
ABOUT LOYOLA MARYMOUNT UNIVERSITY
Loyola Marymount University is one of the nation's top-ranked Catholic universities, recognized by U.S. News & World Report among the top 50 private and top five Jesuit institutions in the country, and among California's top six private schools. Founded in 1911 and rooted in the Catholic, Jesuit, and Marymount traditions, LMU enrolls 7,100 undergraduates and 3,000 graduate and law students across seven colleges and schools. The university offers 56 undergraduate majors, 57 minors, 43 master's degree programs, three doctorate programs, and 12 credential/authorization programs. With top-ranked programs in law, film and television, entrepreneurship, business, and the arts, LMU is embedded in the creative, cultural, and economic life of Los Angeles. The university generates $1.4 billion in annual economic impact. A proud member of the West Coast Conference, LMU fields 14 NCAA Division I teams and competes with purpose, pride, and integrity.
LMU news and events are found at: www.lmu.edu/news.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
a day ago
- Malaysian Reserve
Infectious Disease Testing Market Remains Dynamic Amid Post-Pandemic Shifts and New Innovations
ARLINGTON, Va., June 19, 2025 /PRNewswire/ — Kalorama Information, a trusted source for healthcare market intelligence, released insights into the evolving global market for infectious disease testing through the In Vitro Diagnostics Business Outlook newsletter. Despite the decline in COVID-19 testing, the overall infectious disease diagnostics market remains robust, supported by sustained demand for non-COVID tests and the adoption of next-generation technologies across both laboratory and point-of-care (POC) settings. With testing essential for diagnosing, monitoring, and containing a wide range of infections—from respiratory illnesses and bloodborne viruses to sepsis and gastrointestinal pathogens—the market continues to attract significant attention and investment. Kalorama's latest report highlights a steady shift in growth drivers, with POC solutions, molecular platforms, and advanced immunoassays gaining ground. 'Infectious disease diagnostics continues to be one of the most innovative segments of the IVD industry,' said Daniel Granderson, Senior Editor of Kalorama Information. 'New technologies are not only enhancing diagnostic speed and accuracy but are also reshaping where and how testing is performed—bringing more solutions to decentralized and resource-limited settings.' Highlights from the article include: Strong global demand for lab-based immunoassays and molecular tests Continued innovation in syndromic panels, microfluidics, and cartridge-based POC platforms A growing share of the market shifting toward emerging regions, with Asia Pacific and other developing areas seeing increased diagnostic infrastructure and demand Major industry players—including Roche, Abbott, Danaher, and QIAGEN—introducing new products to address unmet needs in STIs, sepsis, and respiratory diseases The report also profiles emerging innovators bringing AI-powered diagnostics, rapid sepsis panels, and cost-effective molecular tools to market, emphasizing the industry's ongoing focus on speed, accuracy, and accessibility. For more insights on market forecasts, regional dynamics, and comprehensive market views, visit Kalorama Information's IVD Business Outlook. About IVD Business Outlook In Vitro Diagnostics Business Outlook is a bimonthly publication from Kalorama Information, offering six issues annually—each dedicated to a distinct segment of the IVD industry. Designed for decision-makers across diagnostics and life sciences, the publication delivers exclusive market intelligence, including growth forecasts, market sizing, and share analysis. Each issue features in-depth coverage of diagnostic test categories, company profiles, mergers and acquisitions, regional trends, and expert analysis of key industry developments. With curated insights not found in mainstream sources, In Vitro Diagnostics Business Outlook is an essential resource for staying ahead in the global diagnostics market. About Kalorama InformationKalorama Information, a division of Science and Medicine Group, is a leading provider of healthcare market research, delivering actionable intelligence to diagnostics, biotechnology, medical device, and pharmaceutical companies worldwide. Website:
Malaysian Reserve
3 days ago
- Malaysian Reserve
Social and Economic Factors Explain Why Black Patients Lose Less Weight After Bariatric Surgery than Other Groups
NEW YORK, June 18, 2025 /PRNewswire/ — Weight loss surgery has long been an effective treatment for the more than 40 percent of the American adults struggling with obesity. While previous studies show that Black patients lose less weight overall following bariatric surgery compared to other racial groups, less attention has been paid to the relationships between economic and social factors that may help explain differences in weight loss. New research led by NYU Langone Grossman School of Medicine found that Black patients who underwent sleeve gastrectomy, the most common weight loss surgery, between 2017 and 2020 lost 6.2 percent less weight than their White counterparts, and 4.9 percent less than Hispanic patients, after one year. However, further analyses found that a lot more complexity and interplay between non-biological factors than previously known appear to impact weight loss surgery incomes. Published online in the journal Obesity, this is the first study to investigate the relationship between a variety of economic and social factors that include income, sleep disturbances and stress, and weight loss differences among racial groups, the study authors said. 'Our findings identified variations in bariatric surgery outcomes so that we can address them and, when appropriate, offer patients individualized support that can help promote the best possible outcomes,' said Melanie Jay, MD, professor in the Departments of Medicine and Population Health at NYU Langone Health, and senior author of the study. How the Study was Conducted Study participants who self-identified as either Non-Hispanic Black, Hispanic, or Non-Hispanic White were recruited from NYU Langone Health Tisch Hospital and NYC Health + Hospital Bellevue Hospital from June 2017 to March 2020. The researchers measured patients' total weight loss, waist circumference, body composition, hormones, and blood glucose levels—following up with them at multiple intervals through in-clinic visits and questionnaires over two years. Analyzing data from 297 patients, the investigators found that after surgery, non-Hispanic Black patients lost less total weight at nearly every follow-up interval compared to their Hispanic and White counterparts. Black patients also consistently reported higher sleep disturbance, perceived stress, and experiences of discrimination. In contrast, no significant differences in total weight loss were observed between Hispanic and White patients. White patients also were found to have better long-term blood glucose control than both Black and Hispanic patients after follow-up. 'These varied associations highlight how different lived experiences and self-perceptions across racial and ethnic groups can influence surgical outcomes,' said Sally M. Vanegas, PhD, research assistant professor in the Department of Medicine and lead study author. 'Additional research is needed to better understand how a broader range of socioeconomic factors may shape these outcomes.' José O. Alemán, MD, PhD, an endocrinologist at NYU Langone and co-senior author of the study said he and his colleagues will continue analyzing data from the study participants to explore additional biological factors that may influence weight loss surgery outcomes, including changes in gene expression and the microbiome. 'As a clinical community, we have to be honest that these differences exist, as well as reinforce the importance of adopting a holistic approach to care.' In addition to Jay, Alemán and Vanegas, additional collaborators from NYU Langone Health include Silvia Curado, PhD, Boyan Zhou, PhD, Ericka N. Merriwether, PhD, Nicholas Illenberger, PhD, Evelyn Armijos, Ann Marie Schmidt, MD, Christine Ren-Fielding, Manish Parikh, MD, and Brian Elbel, PhD. The study was provided with institutional support from NYU Langone Health and obtained donor support through the J. Ira and Nicki Harris Family Foundation, an AHA Ignition Center Grant (17SFRN33590133), and the Clinical and Translational Science Institute (CTSI), which is supported by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number UL1TR001445. SMV was in part supported by 2T32HL098129 from the National Heart, Lung and Blood Institute. JOA was in part supported by K08DK117064 from the National Institute of Diabetes and Digestive and Kidney Diseases and the Doris Duke Foundation. MJ was in part supported by the National Heart, Lung and Blood Institute (K24 HL165161-01A1). About NYU Langone Health NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient Inc. has ranked NYU Langone No. 1 out of 115 comprehensive academic medical centers across the nation for three years in a row, and U.S. News & World Report recently placed nine of its clinical specialties among the top five in the nation. NYU Langone offers a comprehensive range of medical services with one high standard of care across seven inpatient locations, its Perlmutter Cancer Center, and more than 320 outpatient locations in the New York area and Florida. With $14.2 billion in revenue this year, the system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise. Media Inquiries: Sasha
Malaysian Reserve
3 days ago
- Malaysian Reserve
SEEKING DOGS WITH EXTREME FEAR OF THUNDERSTORMS FOR VETERINARY STUDY IN FLORIDA
Multiple Clinics Participating in Study Evaluating an Investigational Medication With the Goal of Achieving the Medication's Approval by FDA RALEIGH, N.C., June 17, 2025 /PRNewswire/ — Dog owners in Florida—the storm capital of the U.S—now have the opportunity to have their dogs screened for possible inclusion in a clinical study evaluating a potential treatment for severe thunderstorm aversion. The study is evaluating an investigational oral medication given twice-daily during storm season that could offer round-the-clock relief. Participation is free, and qualifying dogs receive all study-related care–including evaluations, diagnostic testing, exams, and medication (or placebo) at no cost. Marilyn Bonner says her dog was 'skittish' of storms and loud noises when living in Pennsylvania, but upon moving to Florida, her Boxer developed intense anxiety. 'Nothing prepared us for the thunderstorms in Florida. They're so intense and so frequent. As soon as one rolls in, she'll start panting and severely shaking. It's heartbreaking.' Dogs With Thunderstorm Aversion Are Suffering Dogs with severe thunderstorm aversion often display their intense fear by hiding, cowering, destructiveness, trembling/shaking, self-harm, and more. Sadly, the fear may begin hours before a storm arrives, and in some cases, take days for dogs to recover. 'During a thunderstorm, my dog never leaves my side; she's there shaking, drooling, and practically hyperventilating. There are times I've thought she was going to have a heart attack,' says Jill Powers, of Southwest Florida. 'I just feel so terrible for her.' In a published study, nearly 50% of dog owners reported their dogs show fear when exposed to noises. What Dogs Can Participate?In order to be eligible, dogs must show signs of thunderstorm aversion, weigh at least 8.8 lbs., be in good general health, and meet certain other criteria. Interested dog owners can visit to see if there's a participating veterinary site nearby and complete a short pre-screening questionnaire. Take Action NowThe study only runs a few months during Florida's storm season, so pet owners interested in signing up their dogs should act quickly. Participation offers pet owners a chance to help their dogs, support research that could lead to a medication approved by the Food & Drug Administration's Center for Veterinary Medicine, and benefit generations of dogs in the future. To learn more, visit About VisionaireVisionaire Research & Education supports patient recruitment for veterinary clinical studies, helping veterinary pharmaceutical Sponsors speed new pet medications to market. The Company's number one priority is helping dogs, cats, and horses — and their owners — experience a better quality of life through innovative treatments and solutions. The pivotal studies Visionaire supports can be a way to gain access to quality diagnostics and veterinary care — and investigational therapies that often aren't available anywhere else — all at no cost to pet owners. For more information, visit Contact: Megan Hepp, 919-293-0243 x 202; megan@
